Correlations between white blood cell count and metabolic syndrome in middle-age Taiwanese

Endocrine Research

Volumn 31, Issue 1, 2005, Pages 39-50

  Chuo, Sing Kai ^a   Li, Jer Chuan ^a   Tsai, Wen Chin ^a   Wu, Du An ^a   Kuo, Shi Wen ^a   Pei, Dee ^a,d   Chen, Sheng Pyng ^b   Shen, De Chang ^c  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b Armed Forces Sung Shan Hospital   (Taiwan)

^c Chung Shan Hospital   (Taiwan)

^d Central Office   (Taiwan)

Author keywords

Insulin resistance; Metabolic syndrome; White blood cell count

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; METABOLIC SYNDROME X; PRIORITY JOURNAL; TAIWAN;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; METABOLIC SYNDROME X; MIDDLE AGED; TAIWAN; TRIGLYCERIDES;

EID: 26444471448     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.1080/07435800500229151     Document Type: Article

References (43)

1. Taiwan Area Main Causes of Death (2002). Table 1- main causes of death in Taiwan. Department of Health, Taiwan. R.O.C. http://www.doh.gov.tw/ufile/Doc/ S02/9101-eng.xls (accessed on Dec 2004).
2. Colwell JA, Winocour PD, Lopes-Virella M, Halushka PV. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med 1983; 75(5B):67-80.
3. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37(12):1595-1607.
4. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med 1998; 15(7):539-553.
5. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 2001; 285(19):2486-2497.
6. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003; 26(3):575-581.
7. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, Morris R, Zavaroni I, van Dam R, Feskins E, Gabriel R, Diet M, Nilsson P, Hedblad B. European Group for the Study of Insulin Resistance (EG1R). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes & Metabolism 2002; 28(5):364-376.
8. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000; 321(7255):199-204.
9. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24(4):683-689.
10. Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974; 290(23):1275-1278.
11. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14(3):173-194.
12. Friedman GD, Tekawa I, Grimm RH, Manolio T, Shannon SG, Sidney S. The leucocyte count: correlates and relationship to coronary risk factors: the CARDIA study. Int J Epidem 1990; 19(4):889-893.
13. Yarnell JW, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991; 83(3):836-844.
14. Nakanishi N, Sato M, Shirai K, Nakajima K, Murakami S, Takatorige T, Suzuki K, Tatara K. Associations between white blood cell count and features of the metabolic syndrome in Japanese male office workers. Ind Health 2002; 40(3):273-277.
15. Nakanishi N, Suzuki K, Tatara K. White blood cell count and clustered features of metabolic syndrome in Japanese male office workers. Occup Med (Oxford) 2002; 52(4):213-218.
16. Marques-Vidal P, Mazoyer E, Bongard V, Gourdy P, Ruidavets JB, Drouet L, Ferneres J. Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 2002; 25(8):1371-1377.
17. Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the third national health and nutrition examination survey. Atherosclerosis 2003; 168(2):351-358.
18. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrin Metab 2003; 88(6):2404-2411.
19. Contreras I, Parra D. Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women. Amer J Health-Sys Pharm 2000; 57(21):1963-1968.
20. Sotelo MM, Johnson SR. The effects of hormone replacement therapy on coronary heart disease. Endocrinol Metab Clin N Amer 1997; 26(2):313-328.
21. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med 1993; 328(15):1069-1075.
22. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20(1):47-63.
23. Vaziri SM, Evans JC, Larson MG, Wilson PW. The impact of female hormone usage on the lipid profile. The Framingham Offspring Study. Arch Int Med 1993; 153(19):2200-2206.
24. Shen BJ, Todaro JF, Niaura R, McCaffery JM, Zhang J, Spiro A 3rd, Ward KD. Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Amer J Epidem 2003; 157(8):701-711.
25. Cavaghan MK, Ehrmann DA, Polonsky KS. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 2000; 106(3):329-333.
26. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990; 12(5):1179-1186.
27. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265(3):621-636.
28. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99(2):237-242.
29. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Amer J Epidem 1996; 144(6):537-547.
30. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342(12):836-843.
31. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, Kuller LH. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arteriosclerosis, Thrombosis & Vascular Biology 1997; 17(6):1121-1127.
32. Fisch IR, Freedman SH. Smoking, oral contraceptives, and obesity. Effects on white blood cell count. JAMA 1975; 234(5):500-506.
33. Pratley RE, Wilson C, Bogardus C. Relation of the white blood cell count to obesity and insulin resistance: effect of race and gender. Obesity Research 1995; 3(6):563-571.
34. Saito I, Yonemasu K, Inami F. Association of body mass index, body fat, and weight gain with inflammation markers among rural residents in Japan. Circulation 2003; 67(4):323-329.
35. Al-Shayji IA, Akanji AO. Obesity indices and major components of metabolic syndrome in young adult Arab subjects. Annals Nutr Metab 2004; 48(1):1-7.
36. Seidell JC, Oosterlee A, Deurenberg P, Hautvast JG, Ruijs JH. Abdominal fat depots measured with computed tomography: effects of degree of obesity, sex, and age. Eur J Clin Nutr 1988; 42(9):805-815.
37. Shen DC, Shieh SM, Fuh MT, Chen YD. Comparison of the effects of differences in ratio of waist to hip girth and body mass index on carbohydrate metabolism in Chinese females. Horm Metab Res 1990; 22(10):533-536.
38. Gillum RF, Mussolino ME. White blood cell count and hypertension incidence. The NHANES I Epidemiologic Follow-up Study. J Clin Epidem 1994; 47(8):911-919.
39. Nakanishi N, Suzuki K, Tatara K. Clustering of cardiovascular risk factors and risk of development of hypertension in Japanese male office workers. J Cardiovas Risk 2003; 10(3):213-220.
40. Hansen LK, Grimm RH Jr, Neaton JD. The relationship of white blood cell count to other cardiovascular risk factors. Int J Epidem 1990; 19(4):881-888.
41. Matsubara M, Namioka K, Katayose S. Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation. Eur J Endocrinol 2003; 148(6):657-62.
42. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 2000; 102(1):42-47.
43. Nakanishi N, Yoshida H, Matsuo Y, Suzuki K, Tatara K. White blood-cell count and the risk of impaired fasting glucose or type II diabetes in middle-aged Japanese men. Diabetologia 2002; 45(1):42-48.